← Back to patent-cliff list
CAS 50978-45-5
1,1,3-Trioxo-1,2-benzothiazole-2-carbaldehyde
Codes: (IX)1116928-1-a
Application context (from source-drug indications)
AtherosclerosisMuvalaplin脂类代谢紊乱MuvalaplinRenal impairmentMuvalaplin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Muvalaplin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(3R)-1-[(1,1-Dimethylethoxy)carbonyl]-3-pyrrolidineacetic acid→(S)-4-Phenylmethyl-2-oxazolidinone→(3R)-3-[2-Oxo-2-[(4S)-2-oxo-4-(phenylmethyl)-3-oxazolidinyl]ethyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester→1-Bromo-3-(bromomethyl)benzene→(3R)-3-[(1S)-1-[(3-Bromophenyl)methyl]-2-oxo-2-[(4S)-2-oxo-4-(phenylmethyl)-3-oxazolidinyl]ethyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester→(2S)-3-(3-Bromophenyl)-2-[(3R)-1-(tert-butoxycarbonyl)pyrrolidin-3-yl]propanoic acid→Ammonium (2S)-3-(3-bromophenyl)-2-[(3R)-1-(tert-butoxycarbonyl)pyrrolidin-3-yl]propanoate→(alphaS,3R)-alpha-[(3-Bromophenyl)methyl]-1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrolidineacetic acid 1,1-dimethylethyl ester→1,1,3-Trioxo-1,2-benzothiazole-2-carbaldehyde→(alphaS,3R)-1-[(1,1-Dimethylethoxy)carbonyl]-alpha-[(3-formylphenyl)methyl]-3-pyrrolidineacetic acid 1,1-dimethylethyl ester→Amino alcohol hydrochloride→(alphaS,3R)-1-[(1,1-Dimethylethoxy)carbonyl]-alpha-[[3-[(E)-(hydroxyimino)methyl]phenyl]methyl]-3-pyrrolidineacetic acid 1,1-dimethylethyl ester→1,1-Dimethylethyl (alphaS,3R)-alpha-[[3-(aminomethyl)phenyl]methyl]-1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrolidineacetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.